Clinical Trial Update: Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating Janus kinase inhibitors for acute severe ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Status: COMPLETED